Originally Posted by
John83
I think the AZ and J&J vaccine issues will amount to little more than bureaucratic hold-up. There'll be guidelines released to prefer other vaccines for certain cohorts - all six of the cases behind the J&J review in the US are women under 50, for example, and the AZ guidelines here seem to be to restrict it to people over 60 - but ultimately the serious side effects seem to be in the "struck by lightning" class of probability and the substantial good they'll do outweighs the rare harm. That is likely to delay rollout a bit, but not that much as pent up supplies can be used up quickly enough when they're released.